Atomistry » Chlorine » PDB 4fbx-4fls » 4fc0
Atomistry »
  Chlorine »
    PDB 4fbx-4fls »
      4fc0 »

Chlorine in PDB 4fc0: Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor

Enzymatic activity of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor

All present enzymatic activity of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor, PDB code: 4fc0 was solved by J.K.Yano, K.Aertgeerts, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 2.95
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 109.968, 109.968, 145.973, 90.00, 90.00, 90.00
R / Rfree (%) 19.8 / 24.3

Other elements in 4fc0:

The structure of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor also contains other interesting chemical elements:

Fluorine (F) 2 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor (pdb code 4fc0). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor, PDB code: 4fc0:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 4fc0

Go back to Chlorine Binding Sites List in 4fc0
Chlorine binding site 1 out of 2 in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl901

b:32.3
occ:1.00
CL2 A:0T2901 0.0 32.3 1.0
C23 A:0T2901 1.7 30.9 1.0
C16 A:0T2901 2.7 32.4 1.0
C12 A:0T2901 2.7 28.9 1.0
O17 A:0T2901 2.9 34.7 1.0
O11 A:0T2901 3.1 25.8 1.0
C10 A:0T2901 3.1 26.3 1.0
C21 A:0T2901 3.1 36.5 1.0
N22 A:0T2901 3.2 37.2 1.0
CD2 A:LEU504 3.3 21.3 1.0
C18 A:0T2901 3.6 35.8 1.0
CA A:GLY592 3.9 24.6 1.0
N A:ASP593 3.9 25.5 1.0
C15 A:0T2901 4.0 32.0 1.0
C13 A:0T2901 4.0 29.8 1.0
N9 A:0T2901 4.1 23.7 1.0
CG A:LEU504 4.2 23.4 1.0
C A:GLY592 4.2 24.6 1.0
CD2 A:LEU513 4.5 17.6 1.0
C14 A:0T2901 4.5 31.1 1.0
CB A:LEU513 4.6 16.9 1.0
C19 A:0T2901 4.6 35.3 1.0
C20 A:0T2901 4.7 36.0 1.0
CD1 A:LEU504 4.7 23.8 1.0
O A:ILE591 4.8 24.0 1.0
CB A:ASP593 4.9 26.9 1.0
CA A:ASP593 5.0 25.9 1.0

Chlorine binding site 2 out of 2 in 4fc0

Go back to Chlorine Binding Sites List in 4fc0
Chlorine binding site 2 out of 2 in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl901

b:36.6
occ:1.00
CL2 B:0T2901 0.0 36.6 1.0
C23 B:0T2901 1.7 32.6 1.0
C16 B:0T2901 2.7 32.7 1.0
C12 B:0T2901 2.7 30.7 1.0
O17 B:0T2901 2.9 33.2 1.0
O11 B:0T2901 3.0 29.0 1.0
C10 B:0T2901 3.1 28.8 1.0
C21 B:0T2901 3.3 33.4 1.0
CD2 B:LEU504 3.3 22.9 1.0
N22 B:0T2901 3.5 33.6 1.0
C18 B:0T2901 3.6 33.5 1.0
CA B:GLY592 3.9 27.8 1.0
C15 B:0T2901 4.0 31.9 1.0
C13 B:0T2901 4.0 30.8 1.0
N B:ASP593 4.1 31.5 1.0
N9 B:0T2901 4.1 26.1 1.0
CG B:LEU504 4.1 23.8 1.0
C20 B:0T2901 4.3 33.1 1.0
C B:GLY592 4.3 28.8 1.0
C14 B:0T2901 4.5 31.2 1.0
CB B:LEU513 4.5 19.1 1.0
O B:ILE591 4.5 24.7 1.0
CD1 B:LEU504 4.6 24.7 1.0
CD2 B:LEU513 4.7 21.1 1.0
C19 B:0T2901 4.9 33.6 1.0
CG2 B:ILE512 5.0 18.6 1.0

Reference:

M.Hirose, M.Okaniwa, T.Miyazaki, T.Imada, T.Ohashi, Y.Tanaka, T.Arita, M.Yabuki, T.Kawamoto, S.Tsutsumi, A.Sumita, T.Takagi, B.C.Sang, J.Yano, K.Aertgeerts, S.Yoshida, T.Ishikawa. Design and Synthesis of Novel Dfg-Out Raf/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitors: 3. Evaluation of 5-Amino-Linked Thiazolo[5,4-D]Pyrimidine and Thiazolo[5,4-B]Pyridine Derivatives. Bioorg.Med.Chem. V. 20 5600 2012.
ISSN: ISSN 0968-0896
PubMed: 22883026
DOI: 10.1016/J.BMC.2012.07.032
Page generated: Sat Dec 12 10:36:49 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy